“…13,[31][32][33][34][35][36][37] IM-MS offers high analytical speed, low sample consumption and the ability to resolve small structural differences in peptide analytes, driven by recent technological advancements in IM-MS. [34][35][36][37][38][39] While molecular dynamics (MD) simulations have been combined with IM-MS to reveal the structural consequences of D-epimerization within small neuropeptides, 40 Li et al has recently reported a multi-dimensional IM-MS (md-IM-MS)-based structural analysis strategy, based on the metal-bound chiral amplication and oligomer-resolved data integration method, to facilitate the study of the chiral effects on monomer structure, oligomeric propensity and receptor binding for Ab fragments. 34,41 However, results from truncated Ab (e.g. Ab Nterminus and core region fragments) cannot be reliably extrapolated to predict those for the full length bioactive Ab forms (e.g.…”